Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Supernus Pharmaceuticals, Inc. (SUPN) $455,900 $1,391,429
2024 Supernus Pharmaceuticals, Inc. (SUPN) $441,034 $1,552,229
2023 Supernus Pharmaceuticals, Inc. (SUPN) $427,700 $1,468,211
2022 Supernus Pharmaceuticals, Inc. (SUPN) $415,200 $1,120,759
2021 Supernus Pharmaceuticals, Inc. (SUPN) $403,100 $933,265
2020 Supernus Pharmaceuticals, Inc. (SUPN) $391,401 $1,074,490
2019 Supernus Pharmaceuticals, Inc. (SUPN) $380,018 $1,311,587
2018 Supernus Pharmaceuticals, Inc. (SUPN) $369,000 $1,229,803
2017 Supernus Pharmaceuticals, Inc. (SUPN) $358,000 $1,063,281

Recent activity

No earnings-call appearances or filed executive changes recorded yet.